Analysts Back Cardinal Health, Lift Merck
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Cardinal Health is the day's standout. Two major banks raised their price targets within minutes of each other. Evercore ISI lifted its target to $270 from $265. Morgan Stanley moved to $265 from $255. Both analysts carry Buy ratings. The consensus target now sits at $263.60, up from $262.53. The $55.9 billion healthcare distributor carries just 2.9% short interest, so there is little short-seller resistance to a rally.
Merck drew the session's most aggressive single call. Daiwa Capital upgraded the pharma giant to Buy from Hold. The analyst set a $143 target — up sharply from $120. That implies roughly 19% upside from current levels. The upgrade lands as Merck's short interest sits at just 1.1% of free float. Daiwa's move pushed the consensus target to $143.
Super Micro Computer saw its consensus target jump to $41.38 from $37.81. That is a 9% lift in one session. Short interest remains elevated at 17.4% of free float. Availability is 168%, so new short positions are still easy to establish. Analysts are warming up — short sellers may not be done yet.
Marriott received a fresh Buy initiation from CICC, adding international coverage to the hotel giant.
Stocks in this article
How this article was generated
- Generated
- 12 Aug 2026, 16:21
- Prompt version
- v1.0
- Data sources
- Analyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.